Curo Vallejos, Yuri FreddyPazo Medina, Greysi Isabel2023-11-092023-11-092021https://hdl.handle.net/20.500.14414/19410El presente estudio retrospectivo - descriptivo se realizó con la finalidad de determinar el comportamiento del consumo de clonazepam 0.5mg y 2mg en una botica del distrito de Trujillo, durante el periodo de Enero – Diciembre 2020. Para esta investigación se consideró datos de las unidades dispensadas de clonazepam y su equivalente comercial (Neuryl®) y el número de clientes atendidas con este medicamento, estos datos fueron obtenidos de la base de datos de la botica y corroborados con el libro de medicamentos Psicotrópicos durante el periodo de enero-diciembre del 2020; se determinó la demanda mensual y anual del clonazepam en dicho periodo resultando un mayor consumo anual para clonazepam 0.5 mg con 514 unidades vendidas, destacando el mes de noviembre con 193 unidades a diferencia del su equivalente farmacéutico, que no presentó ninguna venta en todo el año. Con respecto al clonazepam de 2 mg, tuvo un mayor consumo a diferencia de su equivalente comercial con 77 unidades vendidas resaltando el mes de agosto con 52 unidades dispensadas. Así mismo se hizo una comparativa entre el consumo de clonazepam genérico y comercial, mostrándose el clonazepam genérico como el medicamento más preferido por la población del distrito de Trujillo. También se midió el consumo mensual y anual de medicamentos utilizando el método dosis diaria definida/1000habitantes/día, donde se obtuvo un mayor consumo anual clonazepam 0.5mg y Neuryl® 2mg con un número de DDD/1000 habitantes/día de 3,38 y 7,92 respectivamente.ABSTRACT The present retrospective-descriptive study was carried out in order to determine the behavior of the consumption of clonazepam 0.5mg and 2mg in a pharmacy in the district of Trujillo, during the period of January - December 2020 For this research, data from the units dispensed with clonazepam and its commercial equivalent (Neuryl®) and the number of clients served with this drug were considered, these data were obtained from the pharmacy database and corroborated with the Psychotropic medication book during the January-December 2020 period; The monthly and annual demand for clonazepam was determined in said period, resulting in a higher annual consumption for clonazepam 0.5 mg with 514 units sold, highlighting the month of November with 193 units, unlike its pharmaceutical equivalent, which did not present any sales throughout the year. . With respect to 2 mg clonazepam, it had a higher consumption than its commercial equivalent with 77 units sold, highlighting the month of August with 52 units dispensed. Likewise, a comparison was made between the consumption of generic and commercial clonazepam, showing generic clonazepam as the most preferred drug by the population of the Trujillo district. Monthly and annual drug consumption was also measured using the defined daily dose / 1000 inhabitants / day method, where a higher annual consumption of clonazepam 0.5mg and Neuryl® 2mg was obtained with a number of DDD / 1000 inhabitants / day of 3.38 and 7.92 respectively.application/pdfesinfo:eu-repo/semantics/openAccessClonazepam, establecimiento farmacéutico, DDD, consumo.info:eu-repo/semantics/bachelorThesishttps://purl.org/pe-repo/ocde/ford#3.01.05